Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagus

Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagus

Show other versions (1)

Background: COX-2 expression in tumour cells has been associated with poor prognosis in gastrointestinal and non-gastrointestinal cancers. The aim of our study was to test the hypothesis that higher levels of COX-2 expression are prognostically related to poor clinico-pathologic features in adenocar...

Full description

Bibliographic Details
Main Authors:	Bhandari, Pradeep (Author), Bateman, Adrian C. (Author), Mehta, Raj L. (Author), Stacey, Bernard S.F (Author), Johnson, Penny (Author), Cree, Ian A. (Author), Di Nicolantonio, Federica (Author), Patel, Praful (Author)
Format:	Article
Language:	English
Published:	2006-05.
Subjects:	Article
Online Access:	Get fulltext

Similar Items

Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagus
by: Cree Ian A, et al.
Published: (2006-05-01)

Barrett's oesophagus and adenocarcinoma
by: Lao-Sirieix Pierre, et al.
Published: (2004-05-01)

Effect of Cyclooxygenase (COX)-2 Activation on Diabetic Neuropathy
by: Kellogg, Aaron
Published: (2008)

Cyclooxygenase-2 (COX-2) expression in lymphoma in north-west of Iran
by: Zohreh Sanaat, et al.
Published: (2013-03-01)

Cyclooxygenase-2(COX-2) Expression in Lymphoma in North-West of Iran
by: Seyyed Hadi Chavoshi, et al.
Published: (2013-01-01)

Prediction of a positive circumferential resection margin at surgery following neoadjuvant chemotherapy for adenocarcinoma of the oesophagus
by: W. R. C. Knight, et al.
Published: (2019-12-01)

Epidemiology of Barrett’s oesophagus and oesophageal adenocarcinoma
by: Nancy Perez, et al.
Published: (2019-03-01)

Aspects of Barrett's oesophagus and oesophageal adenocarcinoma
by: Shutt, James
Published: (2010)

Pancreatic Stellate Cells (PSCs) express Cyclooxygenase-2 (COX-2) and pancreatic cancer stimulates COX-2 in PSCs
by: Denham Woody, et al.
Published: (2005-08-01)

Synthesis of benzimidazole analogues as cyclooxygenase-2 (COX-2) inhibitor for anticancer agents
by: Yi Shen, et al.
Published: (2014)

Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management
by: Chitra Rawat, et al.
Published: (2019-10-01)

RNA Interference and cyclooxygenase-2 (COX-2) regulation in colon cancer cells
by: Strillacci, Antonio <1979>
Published: (2008)

Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
by: Harris RE, et al.
Published: (2012-08-01)

Cyclooxygenase (COX) Inhibitors and the Newborn Kidney
by: Wei Qi, et al.
Published: (2012-10-01)

Expression of cyclooxygenase-2(COX-2) in hypopharyngeal cancer and modulation of apoptosis and cell cycle progression by COX-2- specific inhibitors
by: Peng Jyh Ping, et al.
Published: (2003)

Nucleobindin co-localizes and associates with cyclooxygenase (COX)-2 in human neutrophils.
by: Patrick Leclerc, et al.
Published: (2008-05-01)

Role of cyclooxygenases COX-1 and COX-2 in modulating adipogenesis in 3T3-L1 cells
by: Hongyun Yan, et al.
Published: (2003-02-01)

An oncogenic role for gastrin and the CCK-2R in Barrett's oesophagus and oesophageal adenocarcinoma
by: Harris, Joseph C.
Published: (2005)

Different expression of cyclooxygenase-2 (COX-2) in selected nonmelanocytic human cutaneous lesions
by: Barbara W. Chwirot, et al.
Published: (2011-10-01)

Early increased density of cyclooxygenase-2 (COX-2) immunoreactive neurons in Down syndrome
by: Maria Mulet, et al.
Published: (2017-06-01)

Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders
by: Rickinder Sethi, et al.
Published: (2019-09-01)

Reversible suppression of cyclooxygenase 2 (COX-2) expression in vivo by inducible RNA interference.
by: Anne K Zaiss, et al.
Published: (2014-01-01)

Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors
by: Alshafie Galal A, et al.
Published: (2006-01-01)

Cyclooxygenase-2 (cox-2) expression in Barrett's oesphageal epithelium : relationship to inflammation and cancer
by: Abdalla, Salem Ishtiwi
Published: (2005)

Combined chemotherapy with cyclooxygenase-2 (COX-2) inhibitors in treating human cancers: Recent advancement
by: Shuangshuang Li, et al.
Published: (2020-09-01)

Commentary: Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders
by: Clara Westwell-Roper, et al.
Published: (2020-04-01)

Inhibitors of cyclooxygenase-2 (COX-2) and prostate cancer : effects on apoptosis and role in tumour inhibition
by: Mehar, Ayaz
Published: (2005)

A molecular investigation into adenocarcinoma arising in Barrett's oesophagus
by: Hardwick, R. H.
Published: (1995)

The role of diet in the development of Barrett's oesophagus and oesophageal adenocarcinoma
by: Harris, Adrian
Published: (2002)

Identification of molecular markers and risk of Barrett's oesophagus and adenocarcinoma
by: Martino, Erica di
Published: (2005)

The role of p14 in Barrett's oesophagus and associated adenocarcinoma
by: Huang, Y.
Published: (2006)

The role of the type-2 isoform of the cyclooxygenase enzyme (COX-2) in human parturition : potential benefits of selective COX-2 inhibitors in the management of preterm labour
by: Sawdy, Robert John
Published: (2003)

Cyclooxygenase (COX)-2 as a potent molecular target for prevention and therapy of oral cancer
by: Masahiro Urade
Published: (2008-07-01)

Flavocoxid Inhibits Phospholipase A2, Peroxidase Moieties of the Cyclooxygenases (COX), and 5-Lipoxygenase, Modifies COX-2 Gene Expression, and Acts as an Antioxidant
by: Bruce P. Burnett, et al.
Published: (2011-01-01)

The Influence of Glycosylation of Natural and Synthetic Prenylated Flavonoids on Binding to Human Serum Albumin and Inhibition of Cyclooxygenases COX-1 and COX-2
by: Tomasz Tronina, et al.
Published: (2017-07-01)

Similar reductions in the risk of human colon cancer by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
by: Alshafie Galal A, et al.
Published: (2008-08-01)

Cytotoxic of Ganoderma lucidum in Colon Cancer through Cyclooxygenase 2 (COX-2) as Its Molecular Target
by: Agustina Setiawati
Published: (2017-05-01)

The Role of Metabolic Syndrome on Colorectal Adenoma Occurrence and the Association of Cyclooxygenase-2 (COX-2) Expression on the Adenoma
by: Po-JunChen, et al.
Published: (2016)

Cadherin-mediated cell adhesion in the progression of Barrett's oesophagus to adenocarcinoma
by: Bailey, Tracey
Published: (1998)

Sex differences in Barrett's oesophagus in relation to the risk of oesophageal adenocarcinoma
by: Cook, Michael Blaise
Published: (2006)